(12) Patent Application Publication (10) Pub. No.: US 2007/0155661 A1 Kim (43) Pub

Total Page:16

File Type:pdf, Size:1020Kb

(12) Patent Application Publication (10) Pub. No.: US 2007/0155661 A1 Kim (43) Pub US 2007 O155661A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2007/0155661 A1 Kim (43) Pub. Date: Jul. 5, 2007 (54) METHODS AND COMPOSITIONS FOR Related U.S. Application Data MODULATING THE DEVELOPMENT OF STEM CELLS (60) Provisional application No. 60/447,673, filed on Feb. 14, 2003. (75) Inventor: Seung Kim, Stanford, CA (US) Publication Classification Correspondence Address: FSH & NEAVE P GROUP (51) Int. Cl. ROPES & GRAY LLP A6II 38/18 (2006.01) ONE INTERNATIONAL PLACE A6II 38/17 (2006.01) BOSTON, MA 02110-2624 (US) GOIN 33/53 (2006.01) CI2P 2/06 (2006.01) (73) Assignee: THE BOARD of TRUSTEES of the A6II 38/28 (2006.01) LELAND STANDORD JUNOR UNI- (52) U.S. Cl. ............................ 514/12: 435/7.1: 435/69.1; VERSITY, PALO ALTO, CA (US) 530/303 (21) Appl. No.: 10/545,582 (57) ABSTRACT (22) PCT Filed: Feb. 17, 2004 The application provides, among other things, methods for increasing production of insulin in cells by contacting the (86). PCT No.: PCT/USO4/O4639 cells with a BMP family member and/or an activator of a BMP pathway. The application also provides methods for S 371(c)(1), increasing the production of beta cell precursor cells by (2), (4) Date: Nov. 28, 2006 contacting suitable cells with an inhibitor of a BMP pathway. Patent Application Publication Jul. 5, 2007 Sheet 1 of 7 US 2007/0155661 A1 FIGURE I Patent Application Publication Jul. 5, 2007 Sheet 2 of 7 US 2007/0155661 A1 ad C s O S 9 O C e Patent Application Publication Jul. 5, 2007 Sheet 3 of 7 US 2007/0155661 A1 |------ FIGURE 3 Patent Application Publication Jul. 5, 2007 Sheet 4 of 7 US 2007/0155661 A1 a . b A wW-.. ; s r w -A Y as: y s 16 IJ l Patent Application Publication Jul. 5, 2007 Sheet 5 of 7 US 2007/O155661 A1 Patent Application Publication Jul. 5, 2007 Sheet 6 of 7 US 2007/0155661 A1 • ~~~~-:::::::---~~~ .** FIGURE 6 Patent Application Publication Jul. 5, 2007 Sheet 7 of 7 US 2007/0155661 A1 14000 1OOOO 8000 4000 2000 2 3IN AT (s 2uMRA 100M RA Condition f 2 3 8 9 10 1 2 3 4 5 16 TT 8 FIGURE 7 US 2007/O 155661 A1 Jul. 5, 2007 METHODS AND COMPOSITIONS FOR ence of a BMP family member, such as a GDF8/GDF11 MODULATING THE DEVELOPMENT OF STEM subfamily member, or an activator of a BMP signaling CELLS pathway. Optionally, the BMP family member has one or more of the following characteristics: an amino acid CROSS-REFERENCE TO RELATED sequence that is at least 80% identical to a human GDF 11 APPLICATIONS or GDF8; ability to bind to an ActRIIA and/or ActRIIB receptor; an ability to increase Smad2 and/or Smad3 phos 0001. This application claims the benefit of the filing date phorylation in a stem cell; an ability to increases expression of U.S. Provisional Patent Application Ser. No. 60/447,673 of a gene that is positively regulated by Smada. In certain entitled “Methods and Compositions for Modulating the embodiments, the application provides methods for increas Development of Stem Cells' and listing Seung Kim as ing insulin production in a cell composition comprising stem inventor. The aforementioned provisional application is cells, the method comprising contacting the cell composition incorporated herein in its entirety. with a substance that stimulates an ActRIIA and/or ActRIIB signaling pathway. Activators of an ActRIIA and/or ActRIIB BACKGROUND signaling pathway may, for example, cause an increase in 0002 Diabetes mellitus (DM) is a major cause of mor Smad2 and/or Smad3 function or phosphorylation, or bidity and mortality worldwide, and incidence rates of type increase expression of a gene that is positively regulated by I and type II DM are increasing. In type I DM, destruction Smada. A BMP signaling pathway may be activated by of insulin-producing pancreatic islets leads to a prolonged causing overexpression of one or more positive regulators, illness often culminating in devastating multisystem organ such as Smad3, Smad3, or a BMP family member. A BMP failure and early mortality. Clinical trials demonstrate that signaling pathway may also be activated by inhibiting an tight glucose regulation can prevent the development of inhibitor, Such as noggin or chordin. Optionally, the cell diabetic complications, but attempts to achieve this regula composition comprises beta cell precursor cells. In certain tion by exogenous insulin administration are only partially embodiments, the cell composition is derived from embry Successful. onic stem cells that have been cultured in the presence of a 0003 Recent evidence suggests that islet cell transplan retinoid. tation with improved systemic immunosuppression may 0008. In certain embodiments, the application provides a provide a short-term durable remission in insulin require method for promoting the maturation of beta cell precursor ments in type I diabetics (Shapiro et al., 2000, NEngl J Med. cells, the method comprising contacting the beta cell pre 343: 230-238; Ryan et al., 2001, Diabetes 50: 710-719). cursor cells with a BMP family member. However, in DM and the vast majority of other human 0009. In certain aspects the application provides methods diseases amenable to treatment by tissue replacement, there for increasing the number of beta cell precursor cells in a cell is an extreme shortage of engraftable donor tissues. An composition by culturing the cell composition in the pres expandable source of tissues like human stem cells may ence of an antagonist of a BMP signaling pathway. The provide the best promise for tissue replacement strategies for antagonist of a BMP signaling pathway may be a secreted human diseases. polypeptide. Such as noggin, chordin or follistatin that binds 0004 Stem cells, including embryonic stem (ES) cells directly to a BMP family member. and various adult stem cells provide a promising potential 0010. In certain aspects, the application provides cell means for cell-replacement therapy in human diseases. Stem culture methods that employ sequential inhibition and acti cells may provide serve as an inexhaustible source for the vation of a BMP signaling pathway to obtain insulin production of replacement islets for transplantation in dia producing cells. For example, the cells may be cultured in betic humans. However, conditions to produce stably-dif the presence of a noggin, chordin or follistatin and then ferentiated functional insulin-producing cell compositions cultured in the presence of a BMP family member, such as (ICCs) with stem cells generally, and particularly ES stem cells, have not been developed to a clinically satisfactory a member of the GDF8/GDF11 subfamily. Optionally, the level. stem cells are islet precursor cells. 0011. In certain aspects, the application provides methods 0005 Methods to provide a renewable source of replace for ameliorating a condition associated with insufficient ment islets from stem cells could transform therapeutics in pancreatic function by administering a BMP family member, DM. Likewise, methods for stimulating the production of such as a GDF8/GDF 11 subfamily member, or an activator insulin producing cells in patients could also have significant of a BMP signaling pathway. Suitable subjects include those therapeutic effects. that have been diagnosed with type I or type II diabetes. SUMMARY 0012. In certain aspects, the application provides meth ods for increasing the production of beta cell precursor cells 0006. In certain aspects, the application provides meth in a subject, the method comprising administering to the ods for manipulating the development of insulin producing subject a substance that inhibits a BMP signaling pathway, cells and beta cell precursor cells by activating or antago Such as a noggin, chordin or follistatin. In some instances, nizing a BMP signaling pathway. Such methods may be sequential use of BMP pathway antagonists and activators applied, for example, to cultured cells or to subjects in need may be desirable. of improved pancreatic function. 0013 Insulin production in a subject may also be 0007. In certain embodiments, the application provides enhanced by administering a composition comprising insu methods for increasing the production of insulin in a cell lin producing cells produced according to a method of the composition by culturing the cell composition in the pres application. US 2007/O 155661 A1 Jul. 5, 2007 0014. In certain aspects, the application provides meth acinar cell volume in Gdf11 mice. Original magnification ods for assessing the effectiveness of a test agent for 4x(a,b), 16x(de) and 10x(gh) modulating the development of insulin producing cells. For example, a method may comprise: forming a mixture com 0018 FIG. 3. Defective pancreatic islet B-cell and C.-cell prising the test agent and a BMP pathway polypeptide; and numbers in Gdfl 1 deficient mice. (a-c) Immunohistochemi detecting binding between the test agent and the polypep cal detection of insulin (brown staining) at E17.5 in mice tide, wherein a test agent that binds the BMP pathway with the indicated genotypes. (d) Quantification of E17.5 polypeptide specifically and with an affinity of at least f-cell mass by point-counting morphometry in Gdf11" ", 10M has an increased likelihood of being effective for Gdf11", and Gdf11 pancreata. Data are shown as the modulating the development of insulin producing cells. In a average measurements from at least 4 mice of indicated further method embodiment, a cell is cultured with the test genotypeststandard error of the mean. (e-g) Immunohis agent; and an activity of a BMP signaling pathway is tochemical detection of glucagon (brown staining) at E17.5 detected, wherein a test agent that increases the activity of in mice with the indicated genotypes. (h-i) Pancreatic islet a BMP signaling pathway has an increased likelihood of cell expression of insulin (FITC, green) and glucagon (Cy3, being effective for increasing insulin production in a cell.
Recommended publications
  • Spemann Organizer Transcriptome Induction by Early Beta-Catenin, Wnt
    Spemann organizer transcriptome induction by early PNAS PLUS beta-catenin, Wnt, Nodal, and Siamois signals in Xenopus laevis Yi Dinga,b,1, Diego Plopera,b,1, Eric A. Sosaa,b, Gabriele Colozzaa,b, Yuki Moriyamaa,b, Maria D. J. Beniteza,b, Kelvin Zhanga,b, Daria Merkurjevc,d,e, and Edward M. De Robertisa,b,2 aHoward Hughes Medical Institute, University of California, Los Angeles, CA 90095-1662; bDepartment of Biological Chemistry, University of California, Los Angeles, CA 90095-1662; cDepartment of Medicine, University of California, Los Angeles, CA 90095-1662; dDepartment of Microbiology, University of California, Los Angeles, CA 90095-1662; and eDepartment of Human Genetics, University of California, Los Angeles, CA 90095-1662 Contributed by Edward M. De Robertis, February 24, 2017 (sent for review January 17, 2017; reviewed by Juan Larraín and Stefano Piccolo) The earliest event in Xenopus development is the dorsal accumu- Wnt8 mRNA leads to a dorsalized phenotype consisting entirely of lation of nuclear β-catenin under the influence of cytoplasmic de- head structures without trunks and a radial Spemann organizer terminants displaced by fertilization. In this study, a genome-wide (9–11). Similar dorsalizing effects are obtained by incubating approach was used to examine transcription of the 43,673 genes embryos in lithium chloride (LiCl) solution at the 32-cell stage annotated in the Xenopus laevis genome under a variety of con- (12). LiCl mimics the early Wnt signal by inhibiting the enzymatic ditions that inhibit or promote formation of the Spemann orga- activity of glycogen synthase kinase 3 (GSK3) (13), an enzyme nizer signaling center.
    [Show full text]
  • BMP3 Suppresses Osteoblast Differentiation of Bone Marrow Stromal Cells Via Interaction with Acvr2b
    MUShare Faculty Publications and Research College of Osteopathic Medicine 1-1-2012 BMP3 Suppresses Osteoblast Differentiation of Bone Marrow Stromal Cells Via Interaction With Acvr2b. Shoichiro Kokabu Laura Gamer Karen Cox Jonathan W. Lowery Ph.D. Marian University - Indianapolis, [email protected] Kunikazu Tsuji See next page for additional authors Follow this and additional works at: https://mushare.marian.edu/com_fp Part of the Cells Commons, and the Genetics and Genomics Commons Recommended Citation Kokabu S, Gamer L, Cox K, Lowery JW, Kunikazu T, Econimedes A, Katagiri T, Rosen V. “BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b.” Mol Endocrinol. 2012;26(1):87-94. PMC3248326. PMID: 22074949. This Article is brought to you for free and open access by the College of Osteopathic Medicine at MUShare. It has been accepted for inclusion in Faculty Publications and Research by an authorized administrator of MUShare. For more information, please contact [email protected]. Authors Shoichiro Kokabu, Laura Gamer, Karen Cox, Jonathan W. Lowery Ph.D., Kunikazu Tsuji, Regina Raz, Aris Economides, Takenobu Katagiri, and Vicki Rosen This article is available at MUShare: https://mushare.marian.edu/com_fp/12 ORIGINAL RESEARCH BMP3 Suppresses Osteoblast Differentiation of Bone Marrow Stromal Cells via Interaction with Acvr2b Shoichiro Kokabu, Laura Gamer, Karen Cox, Jonathan Lowery, Kunikazu Tsuji, Regina Raz, Aris Economides, Takenobu Katagiri, and Vicki Rosen Department of Developmental Biology (S.K., L.G., K.C., J.L., V.R.), Harvard School of Dental Medicine, Boston, Massachusetts 02115; Section of Orthopedic Surgery (K.T.),Tokyo Medical and Dental University, Tokyo 113-8510, Japan; Regeneron Pharmaceuticals (R.R., A.E.), Tarrytown, New York 10591; and Division of Pathophysiology (T.K.), Saitama Medical University, Saitama 359-8513, Japan Enhancing bone morphogenetic protein (BMP) signaling increases bone formation in a variety of settings that target bone repair.
    [Show full text]
  • Follistatin and Noggin Are Excluded from the Zebrafish Organizer
    DEVELOPMENTAL BIOLOGY 204, 488–507 (1998) ARTICLE NO. DB989003 Follistatin and Noggin Are Excluded from the Zebrafish Organizer Hermann Bauer,* Andrea Meier,* Marc Hild,* Scott Stachel,†,1 Aris Economides,‡ Dennis Hazelett,† Richard M. Harland,† and Matthias Hammerschmidt*,2 *Max-Planck Institut fu¨r Immunbiologie, Stu¨beweg 51, 79108 Freiburg, Germany; †Department of Molecular and Cell Biology, University of California, 401 Barker Hall 3204, Berkeley, California 94720-3204; and ‡Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591-6707 The patterning activity of the Spemann organizer in early amphibian embryos has been characterized by a number of organizer-specific secreted proteins including Chordin, Noggin, and Follistatin, which all share the same inductive properties. They can neuralize ectoderm and dorsalize ventral mesoderm by blocking the ventralizing signals Bmp2 and Bmp4. In the zebrafish, null mutations in the chordin gene, named chordino, lead to a severe reduction of organizer activity, indicating that Chordino is an essential, but not the only, inductive signal generated by the zebrafish organizer. A second gene required for zebrafish organizer function is mercedes, but the molecular nature of its product is not known as yet. To investigate whether and how Follistatin and Noggin are involved in dorsoventral (D-V) patterning of the zebrafish embryo, we have now isolated and characterized their zebrafish homologues. Overexpression studies demonstrate that both proteins have the same dorsalizing properties as their Xenopus homologues. However, unlike the Xenopus genes, zebrafish follistatin and noggin are not expressed in the organizer region, nor are they linked to the mercedes mutation. Expression of both genes starts at midgastrula stages.
    [Show full text]
  • Nodal Signaling Is Required for Mesodermal and Ventral but Not For
    © 2015. Published by The Company of Biologists Ltd | Biology Open (2015) 4, 830-842 doi:10.1242/bio.011809 RESEARCH ARTICLE Nodal signaling is required for mesodermal and ventral but not for dorsal fates in the indirect developing hemichordate, Ptychodera flava Eric Röttinger1,2,3,*, Timothy Q. DuBuc4, Aldine R. Amiel1,2,3 and Mark Q. Martindale4 ABSTRACT early fate maps of direct and indirect developing hemichordates, are Nodal signaling plays crucial roles in vertebrate developmental similar to those of indirect-developing echinoids (Colwin and processes such as endoderm and mesoderm formation, and axial Colwin, 1951; Cameron et al., 1987; Cameron et al., 1989; Cameron patterning events along the anteroposterior, dorsoventral and left- and Davidson, 1991; Henry et al., 2001). While the bilaterally right axes. In echinoderms, Nodal plays an essential role in the symmetric echinoderm larvae exhibit strong similarities to establishment of the dorsoventral axis and left-right asymmetry, but chordates in axial patterning and germ layer specification events, not in endoderm or mesoderm induction. In protostomes, Nodal adult body plan comparisons in echinoderms have been difficult due signaling appears to be involved only in establishing left-right to their unique adult pentaradial symmetry. However, both the larval asymmetry. Hence, it is hypothesized that Nodal signaling has and adult body plans of enteropneust hemichordates are bilaterally been co-opted to pattern the dorsoventral axis of deuterostomes and symmetric, and larvae from indirect developing hemichordates for endoderm, mesoderm formation as well as anteroposterior such as Ptychodera flava (P. flava) share similarities in patterning in chordates. Hemichordata, together with echinoderms, morphology, axial organization, and developmental fate map with represent the sister taxon to chordates.
    [Show full text]
  • Secreted Bone Morphogenetic Protein Antagonists of the Chordin Family
    Article in press - uncorrected proof BioMol Concepts, Vol. 1 (2010), pp. 297–304 • Copyright ᮊ by Walter de Gruyter • Berlin • New York. DOI 10.1515/BMC.2010.026 Review Secreted bone morphogenetic protein antagonists of the Chordin family Nobuyuki Itoha,* and Hiroya Ohtaa factor b (TGFb) superfamily. Originally identified in the Department of Genetic Biochemistry, Kyoto University protein extracts of deminerized bone, BMPs promote endo- Graduate School of Pharmaceutical Sciences, Sakyo, chondral bone formation. However, they also play diverse Kyoto 606-8501, Japan roles in developmental and metabolic processes at the embry- onic and postnatal stages. BMPs are secreted as dimers and * Corresponding author activate specific Ser/Thr kinase receptors at cell surfaces. e-mail: [email protected] The activated receptors propagate BMP signals via the phos- phorylation of Smad proteins and other non-canonical intra- Abstract cellular effectors (1, 2). The actions of BMPs are inhibited by several secreted Chordin, Chordin-like 1, and Chordin-like 2 are secreted BMP antagonists. Most extracellular BMP antagonists inhibit bone morphogenetic protein (BMP) antagonists with highly BMPs by binding to them. The amino acid sequences of conserved Chordin-like cysteine-rich domains. Recently, secreted BMP antagonists are characterized by cysteine-rich Brorin and Brorin-like have been identified as new Chordin- (CR) domains. On the basis of the spacing of cysteine resi- like BMP antagonists. A Chordin ortholog, Short gastrula- dues in the CR domains, secreted BMP antagonists can be tion, has been identified in Drosophila, a protostome, but not classified into five groups; the Dan family, Twisted gastru- other orthologs.
    [Show full text]
  • Differential Compartmentalization of BMP4/NOGGIN Requires NOGGIN Trans-Epithelial Transport
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.18.423440; this version posted December 19, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Differential compartmentalization of BMP4/NOGGIN requires NOGGIN trans-epithelial transport Tien Phan-Everson1-2 +, Fred Etoc1 +, Ali H. Brivanlou1 *, Eric D. Siggia2 * 1 Laboratory of Stem Cell Biology and Molecular Embryology, The Rockefeller University, New York, New York 10065, USA. 2 Laboratory of Physical, Mathematical, and Computational Biology, The Rockefeller University, New York, New York 10065, USA. + Co-first Authors * Joint Corresponding Authors Correspondence: [email protected]; [email protected] Summary Using self-organizing human models of gastrulation, we previously showed that (i) BMP4 initiates the cascade of events leading to gastrulation; (ii) BMP4 signal-reception is restricted to the basolateral domain; and (iii) in a human-specific manner, BMP4 directly induces the expression of NOGGIN. Here, we report the surprising discovery that in human epiblasts, NOGGIN and BMP4 were secreted into opposite extracellular spaces. Interestingly, apically-presented NOGGIN could inhibit basally-delivered BMP4. Apically-imposed microfluidic flow demonstrated that NOGGIN traveled in the apical extracellular space. Our co-localization analysis detailed the endocytotic route that trafficked NOGGIN from the apical space to the basolateral intercellular space where BMP4 receptors were located. This apical-to-basal transcytosis was indispensable for NOGGIN inhibition. Taken together, the segregation of activator/inhibitor into distinct extracellular spaces challenges classical views of morphogen movement.
    [Show full text]
  • Effective Inhibition of Bone Morphogenetic Protein Function By
    Published OnlineFirst September 8, 2015; DOI: 10.1158/1535-7163.MCT-14-0956 Small Molecule Therapeutics Molecular Cancer Therapeutics Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies Silvia Calpe1, Koen Wagner2, Mohamed El Khattabi3, Lucy Rutten3, Cheryl Zimberlin4, Edward Dolk3, C. Theo Verrips3, Jan Paul Medema4, Hergen Spits2, and Kausilia K. Krishnadath1,5 Abstract Bone morphogenetic proteins (BMP) have important but signaling. Epitope binning and docking modeling have shed distinct roles in tissue homeostasis and disease, including light into the basis for their BMP specificity. As opposed to the carcinogenesis and tumor progression. A large number of BMP wide structural reach of natural inhibitors, these small mole- inhibitors are available to study BMP function; however, as culestargetthegroovesandpocketsofBMPsinvolvedin most of these antagonists are promiscuous, evaluating specific receptor binding. In organoid experiments, specific inhibition effectsofindividualBMPsisnotfeasible.Becausetheonco- of BMP4 does not affect the activation of normal stem cells. genic role of the different BMPs varies for each neoplasm, Furthermore, in vitro inhibition of cancer-derived BMP4 non- highly selective BMP inhibitors are required. Here, we describe canonical signals results in an increase of chemosensitivity the generation of three types of llama-derived heavy chain in a colorectal cancer cell line. Therefore, because of their variable domains (VHH) that selectively bind to either BMP4, high specificity and low off-target effects, these VHHs could þ to BMP2 and 4, or to BMP2, 4, 5, and 6. These generated VHHs represent a therapeutic alternative for BMP4 malignancies. have high affinity to their targets and are able to inhibit BMP Mol Cancer Ther; 14(11); 2527–40.
    [Show full text]
  • The Pitx2:Mir-200C/141:Noggin Pathway Regulates Bmp Signaling
    3348 RESEARCH ARTICLE STEM CELLS AND REGENERATION Development 140, 3348-3359 (2013) doi:10.1242/dev.089193 © 2013. Published by The Company of Biologists Ltd The Pitx2:miR-200c/141:noggin pathway regulates Bmp signaling and ameloblast differentiation Huojun Cao1,*, Andrew Jheon2,*, Xiao Li1, Zhao Sun1, Jianbo Wang1, Sergio Florez1, Zichao Zhang1, Michael T. McManus3, Ophir D. Klein2,4 and Brad A. Amendt1,5,‡ SUMMARY The mouse incisor is a remarkable tooth that grows throughout the animal’s lifetime. This continuous renewal is fueled by adult epithelial stem cells that give rise to ameloblasts, which generate enamel, and little is known about the function of microRNAs in this process. Here, we describe the role of a novel Pitx2:miR-200c/141:noggin regulatory pathway in dental epithelial cell differentiation. miR-200c repressed noggin, an antagonist of Bmp signaling. Pitx2 expression caused an upregulation of miR-200c and chromatin immunoprecipitation assays revealed endogenous Pitx2 binding to the miR-200c/141 promoter. A positive-feedback loop was discovered between miR-200c and Bmp signaling. miR-200c/141 induced expression of E-cadherin and the dental epithelial cell differentiation marker amelogenin. In addition, miR-203 expression was activated by endogenous Pitx2 and targeted the Bmp antagonist Bmper to further regulate Bmp signaling. miR-200c/141 knockout mice showed defects in enamel formation, with decreased E-cadherin and amelogenin expression and increased noggin expression. Our in vivo and in vitro studies reveal a multistep transcriptional program involving the Pitx2:miR-200c/141:noggin regulatory pathway that is important in epithelial cell differentiation and tooth development.
    [Show full text]
  • TGF Beta Signaling Pathway 1 TGF Beta Signaling Pathway
    TGF beta signaling pathway 1 TGF beta signaling pathway The Transforming growth factor beta (TGFβ) signaling pathway is involved in many cellular processes in both the adult organism and the developing embryo including cell growth, cell differentiation, apoptosis, cellular homeostasis and other cellular functions. In spite of the wide range of cellular processes that the TGFβ signaling pathway regulates, the process is relatively simple. TGFβ superfamily ligands bind to a type II receptor, which recruits and phosphorylates a type I receptor. The type I receptor then phosphorylates receptor-regulated SMADs (R-SMADs) which can now bind the coSMAD SMAD4. R-SMAD/coSMAD complexes accumulate in the nucleus where they act as transcription factors and participate in the regulation of target gene expression. Mechanism Ligand Binding The TGF Beta superfamily of ligands include: Bone morphogenetic proteins (BMPs), Growth and differentiation factors (GDFs), Anti-müllerian hormone (AMH), Activin, Nodal and TGFβ's[1] . Signalling begins with the binding of a TGF beta superfamily ligand to a TGF beta type II receptor. The type II receptor is a serine/threonine receptor kinase, which catalyses the phosphorylation of the Type I receptor. Each class of ligand binds to a specific type II receptor[2] .In mammals there are seven known type I receptors and five type II receptors[3] . There are three activins: Activin A, Activin B and Activin AB. Activins are involved in embryogenesis and osteogenesis. They also regulate many hormones including pituitary, gonadal and hypothalamic hormones as well as insulin. They are also nerve cell survival factors. The BMPs bind to the Bone morphogenetic protein receptor type-2 (BMPR2).
    [Show full text]
  • Early Formation of the Müllerian Duct Is Regulated by Sequential Actions Of
    © 2016. Published by The Company of Biologists Ltd | Development (2016) 143, 3549-3559 doi:10.1242/dev.137067 RESEARCH ARTICLE Early formation of the Müllerian duct is regulated by sequential actions of BMP/Pax2 and FGF/Lim1 signaling Yuji Atsuta1,* and Yoshiko Takahashi1,2,‡ ABSTRACT and MD form in close proximity, suggesting the possibility of The Müllerian duct (MD) and Wolffian duct (WD) are embryonic reciprocal interactions. tubular tissues giving rise to female and male reproductive tracts, In humans, approximately 3% of births are accompanied by respectively. In amniote embryos, both MD and WD emerge in both female reproductive tract-related disorders, including the Müllerian sexes, but subsequently degenerate in the males and females, aplasia, a congenital loss of the uterus and vagina (Ayers et al., respectively. Here, by using MD-specific gene manipulations in 2015; Kobayashi and Behringer, 2003; Layman, 2013; Sandbacka chicken embryos, we identify the molecular and cellular mechanisms et al., 2013). To understand how these disorders arise, it is important that link early MD specification to tubular invagination. Early (pre-) to delineate the mechanisms of MD formation. specification of MD precursors in the coelomic epithelium requires During embryonic development in both sexes, the MD arises BMP signaling and its downstream target Pax2 in a WD-independent from the lateral plate-derived coelomic epithelium (CE). The process. Subsequently, the BMP/Pax2 axis induces Lim1 processes of MD development can be divided into distinct phases: expression, a hallmark of MD specification, for which FGF/ERK and initiation, invagination and extension (Orvis and Behringer, 2007). WD-derived signals are also required.
    [Show full text]
  • The Zinc Finger Gene Xblimp1 Controls Anterior Endomesodermal Cell Fate
    The EMBO Journal Vol.18 No.21 pp.6062–6072, 1999 The zinc finger gene Xblimp1 controls anterior endomesodermal cell fate in Spemann’s organizer Fla´ vio S.J.de Souza, Volker Gawantka, give rise to liver, foregut and prechordal endomesoderm Aitana Perea Go´ mez1, Hajo Delius2, (Pasteels, 1949; Nieuwkoop and Florschu¨tz, 1950; Keller, Siew-Lan Ang1 and Christof Niehrs3 1991; Bouwmeester et al., 1996). The activity of one gene expressed in the anterior endomesoderm, cerberus, has Division of Molecular Embryology and 2Division of Applied Tumour given strong molecular support to the idea that this region Virology, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld is crucial in the process of head induction (reviewed in 280, D-69120 Heidelberg, Germany and 1Institut de Ge´ne´tique et de Biologie Moleculaire et Cellulaire, CNRS/INSERM/Universite´ Louis Slack and Tannahill, 1992; Gilbert and Saxen, 1993; Pasteur/Colle`ge de France, BP163, 67404 Illkirch cedex, Bouwmeester and Leyns, 1997; Niehrs, 1999). Cerberus CU de Strasbourg, France is a secreted factor able to induce ectopic heads including 3Corresponding author forebrain, eye, cement gland and heart in Xenopus (Bouwmeester et al., 1996). Independent evidence for the The anterior endomesoderm of the early Xenopus importance of endoderm in forebrain induction comes gastrula is a part of Spemann’s organizer and is from studies in mouse, where ablation of anterior visceral important for head induction. Here we describe endodermal cells (Thomas and Beddington, 1996) as well Xblimp1, which encodes a zinc finger transcriptional as inactivation of genes such as nodal (Varlet et al., 1997) repressor expressed in the anterior endomesoderm.
    [Show full text]
  • The Regulation of Mesodermal Progenitor Cell Commitment to Somitogenesis Subdivides the Zebrafish Body Musculature Into Distinct Domains
    Downloaded from genesdev.cshlp.org on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press The regulation of mesodermal progenitor cell commitment to somitogenesis subdivides the zebrafish body musculature into distinct domains Daniel P. Szeto1 and David Kimelman2 Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA The vertebrate musculature is produced from a visually uniform population of mesodermal progenitor cells (MPCs) that progressively bud off somites populating the trunk and tail. How the MPCs are regulated to continuously release cells into the presomitic mesoderm throughout somitogenesis is not understood. Using a genetic approach to study the MPCs, we show that a subset of MPCs are set aside very early in zebrafish development, and programmed to cell-autonomously enter the tail domain beginning with the 16th somite. Moreover, we show that the trunk is subdivided into two domains, and that entry into the anterior trunk, posterior trunk, and tail is regulated by interactions between the Nodal and bone morphogenetic protein (Bmp) pathways. Finally, we show that the tail MPCs are held in a state we previously called the Maturation Zone as they wait for the signal to begin entering somitogenesis. [Keywords: Bmp signaling; Nodal; T-box genes; MZoep; somite] Supplemental material is available at http://www.genesdev.org. Received March 29, 2006; revised version accepted May 12, 2006. The mesodermal progenitor cells (MPCs) are a popula- the presomitic mesoderm (Griffin and Kimelman 2002) tion of undifferentiated progenitor cells that originate in (this zone is not the same as the maturation front at the the early gastrula embryo (for review, see Schier et al.
    [Show full text]